Citalopram HBR 20 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB25FJXRH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,132
Award facts
- Contract value 100% obligated
- $3,132.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Citalopram HBr 20 mg tablets (500-count) with a ceiling value of $3,132.17. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by August 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly supplies critical medications to federal medical procurement channels through its DLA contracts. The company's portfolio encompasses generic and brand-name pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. Citalopram is a selective serotonin reuptake inhibitor (SSRI) commonly used in military and veteran healthcare systems for the treatment of depression and anxiety disorders. All of AmerisourceBergen's reviewed DLA contract awards have been competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement standards across a wide range of medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FJXRH?
SPE2DB25FJXRH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FJXRH worth?
The government has obligated $3,132 on SPE2DB25FJXRH.
Is contract SPE2DB25FJXRH an order under another contract?
Yes. SPE2DB25FJXRH is a delivery order under SPE2DB24D2217, an indefinite delivery contract.
Was contract SPE2DB25FJXRH competed?
The extent of competition for SPE2DB25FJXRH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award